Business Case

Loss of Exclusivity impact analysis

A large pharmaceutical company was grappling with the challenge of understanding the expected economic impact of generic entry when their branded product lost exclusivity in several countries. LSC was able to craft a robust tool capable of analyzing clinical and market information specific to each country, including technical evidence, local pricing of the branded drug, treatment scenario, and number of expected generic entrants. In whole, the instrument allowed the company to have a tangible, precise instrument to understand the value of the branded product, but also bolstered the market strategy and regional pricing decision-making processes.